Astex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference DUBLIN, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that Mohammad Azab, MD, chief medical officer, and Michael Molkentin, chief financial officer, will present at the 2013 RBC Capital Markets Healthcare Conference on Wednesday, February 27^th in New York City. The Company's presentation will begin at 8:00 a.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's website, www.astx.com. The webcast will be archived for 30 days. About Astex Pharmaceuticals Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies.Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales. For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com. The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273 CONTACT: Timothy L. Enns Astex Pharmaceuticals, Inc. Senior Vice President Corporate Communications & Marketing Tel: +1 (925) 560-2810 E-mail: firstname.lastname@example.org Susanna Chau Astex Pharmaceuticals, Inc. Manager Investor Relations Tel: +1 (925) 560-2845 E-mail: email@example.com Alan Roemer The Trout Group Managing Director Tel: +1 (646) 378-2945 E-mail: firstname.lastname@example.org Astex Pharmaceuticals, Inc. logo
U.S. Said to Limit Visitors From Ebola Nations to Five Airports
Astex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.